References
- Anonymous (1997). A1AT deficiency: Memorandum from WHO meeting. WHO Bulletin OMS. 75, 397-415.
- Beckman, G., Beckman, L., Nordenson, I. (1980). Alpha 1-antitrypsin phenotypes in Northern Sweden. Hum. Her. 30, 129-135.
- Beckman, L., Ambrasiene, D., Krumina, A., Kucinskas, V., Mikelsaar, A.V., Sikstrom, C. (1999). A1AT (PI) alleles as markers of West European influence in the Baltic Sea region. Hum. Her. 49, 52-55.
- Berg, N.O., Eriksson, S. (1972). Liver disease in adults with alpha-1-antitrypsin deficiency. New Eng. J. Med., 287, 1265-1267.
- Blanco, I., Fernandez, E., Bustillo, E.F. (2001). Alpha-1-antitrypsin PI phe-notypes S and Z in Europe: An analysis of the published surveys. Clin. Genet., 60, 31-41.
- Bowlus, C.L., Willner, I., Zern, M.A., Rauben, A., Chen, P. et al. (2005). Factors associated with advanced liver disease in adults with alpha1-antitrypsin deficiency. Clin. Gastroenterol. Hepatol. 3(4), 390-396.
- Brantly, M.L., Wittes, J.T., Vogelmeier, C.F., Hubbard, R.C., Fells, G.A. (1991). Use of a highly purified alpha 1-antitrypsin standard to establish ranges for the common normal and deficient alpha 1-antitrypsin pheno-types. Chest. 100(3), 703-708.
- Byth, B.C., Billingsley, G.D., Cox, D.W. (1994). Physical and genetic mapping of the serpin gene cluster at 14q32.1: Allelic association and a unique haplotype associated with alpha 1-antitrypsin deficiency. Amer. J. Hum. Genet., 55, 126-133.
- Callea, F., Gregorini, G., Sinico, A. (1997). Alpha 1-antitrypsin deficiency and ANCA-positive systemic vasculitis: Genetic and clinical implications. Eur. J. Clin. Invest., 27(8), 696-702.
- Carrell, R.W., Lomas, D.A. (2002). Alpha-1-antitrypsin deficiency — a model for conformational diseases. New Eng. J. Med. 346, 45-53.
- Cox, D.W., Billingsley, G.D., Mansfield, T. (1987). DNA restriction site polymorphisms associated with the alpha 1-antitrypsin gene.Amer. J. Hum. Genet., 41, 891-906.
- Cox, D.W., Woo, S.L., Mansfield, T. (1985). DNA restriction fragments associated with alpha1-antitrypsin indicate a single origin for deficiency allele PIZ. Nature, 316, 79-81.
- Dirksen, A., Dijkman, J.H., Madsen, F., Stoel, B., Hutchison, D.C.S., et al. (1999). A randomized clinical trial of alpha antitrypsin augmentation therapy. Amer. J. Respir. Crit. Care. Med., 160, 1468-1472.
- Elliot, P.R., Bilton, D., Lomas, D.A. (1998). Lung polymers in Z A1AT deficiency related Emphysema. Amer. J. Respir. Cell. Mol. Biol., 18(5), 670-674.
- Eriksson, S. (1989). Alpha 1-antitrypsin deficiency: Lessons learned from the bedside to the gene and back again. Historic perspectives. Chest, 95(1), 181-189.
- Ferguson, G.T. (2000). Update on pharmacologic therapy for chronic obstructive pulmonary disease. Clin. Chest. Med. 21(4), 723-738.
- Hutchison, D.C. (1998). Alpha-1-antitrypsin deficiency in Europe: Geographical distribution of PI types S and Z. Resp. Med., 92, 367-377.
- Lace, B., Sveger, T., Krams, A., Cernevska, G., Krumina, A. (2008). Age of SERPINA1 gene PI Z mutation: Swedish and Latvian population analysis. Ann. Hum. Genet., 72, 300-304.
- Lai, E.C., Kao, F.T., Law, M.L., Woo, S.L. (1983). Assignment of the alpha 1-antitrypsin gene and a sequence-related gene to human chromosome 14 by molecular hybridization. Amer. J. Hum. Genet., 35(3), 385-392.
- Laurell, C.B., Eriksson, S. (1965). The serum alpha-l-antitrypsin in families with hypo-alpha-l-antitrypsinemia. Clin. Chim. Acta., 11, 395-398.
- Lomas, D.A., Mahadeva, R. (2002). Alpha1-antitrypsin polymerization and the serpinopathies: Pathobiology and prospects for therapy. J. Clin. Invest., 110(11), 1585-1590.
- Long, G.L., Chandra, T., Woo, S.L.C., Davie, E.W., Kurachi, K. (1984). Complete sequence of the cDNA for Human alpha-antitrypsin and the gene for the S variant. Biochemistry, 23, 4828-4837.
- Lopez, A.D., Murray, C.C. (1998). The global burden of disease, 1990-2020. Nat. Med., 4(11), 1241-1243.
- Luisetti, M., Seersholm, N. (2004). Alpha1-antitrypsin deficiency. 1: Epidemiology of alpha1-antitrypsin deficiency. Thorax, 59(2), 164-169.
- Mayer, A., Stoller, J.K., Bartelson, B.B., Rutteber, A.J., Sandhaus, R.A. et al. (2000). Occupational exposure risks in individuals with PIZ į1-antitrypsin deficiency. Amer. J. Respir. Crit. Care. Med., 162, 553-558.
- Nukiwa, T., Satoh, K., Brantly, M.L., Ogushi, F., Fells, G.A., Courtney, M. et al. (1986). Identification of a second mutation in the protein-coding sequence of the Z type alpha 1-antitrypsin gene. J. Biol. Chem., 261(34), 15989-15994.
- Permutter, D.H. (1998). Alpha 1-antitrypsin deficiency. Semin. Liver Dis., 18(3), 217-225.
- Piitulainen, E., Sveger, T. (2002). Respiratory symptoms and lung function in young adults with severe A1AT deficiency. Thorax, 57(8), 705-708.
- Potempa, J., Korzus, E., Travis, J. (1994). The Serpin super family of protease inhibitors: Structure, functions and regulations. J. Biol. Chem., 269(23), 15957-15960.
- Rannala, B., Bertorelle, G. (2001). Using linked markers to infer the age of a mutation. Hum. Mut., 18, 87-100.
- Seersholm, N., Kok-Jensen, A. (1995). Survival in relation to lung function and smoking cessation in patients with severe hereditary alpha antitrypsin deficiency. Amer. J. Respir. Crit. Care. Med., 151, 369-373.
- Seixas, S., Garcia, O., Trovoada, M.J., Santos, M.T., Amorim, A., Rosha, J. (2001). Patterns of haplotype diversity within the Serpin gene cluster at 14q32.1: Insights into the natural history of the alpha 1 antitrypsin polymorphism. Hum. Genet., 108, 20-30.
- Strange, C., Stoller, J.K., Sandhaus, R.A., Dickson, R., Turino, G. (2006). Results of a survey of patients with alpha-1 antitrypsin deficiency. Respiration, 73(2), 185-190.
- Sveger, T., Eriksson, S. (1995). The liver in adolescents with alpha-1-antitrypsin deficiency. Hepatology, 22(2), 514-517.
- Sveger, T., Thelin, T. (2000). A future for neonatal Alpha 1-Antitrypsin screening? Acta Paediatr., 89, 259-261.
- Sveger, T. (1976). Liver disease in alpha1-antitrypsin deficiency detected by screening of 200,000 infants. New Eng. J. Med., 294, 1316-1321.
- Techman, J.H., Lindblad, D. (2006). Alpha-1-antitrypsin deficiency: Diagnosis, pathophysiology, and management. Curr. Gastroenterol. Rep., 8(1), 14-20.
- Tobin, M.J., Cook, P.J.L., Hutchinson, C.S. (1983). Alpha 1-antitrypsin deficiency: The clinical and physiological features of pulmonary emphysema in subjects homozygous for PI type Z. Brit. J. Dis. Chest., 77(14), 14-27.
- Walker, M.B., Retzinger, A.C., Retzinger, G.S. (2006). A turbidimetric method for measuring the activity of trypsin and its inhibition. Anal. Biochem. 351(1), 114-121.
- Wencker, M., Banik, N., Buhl, R., Seidel, R., Konietzko, N. (1998). Long term treatment of alpha antitrypsin deficiency-related pulmonary emphysema with human antitrypsin. Eur. Respir. J., 11, 428-433.
- Wewers, M.D., Casolaro, A., Sellers, S., Swayze, S.C., McPhaul, K.M. et al. (1987). Replacement therapy for alpha-1-antitrypsin deficiency associated with emphysema. New Eng. J. Med., 316, 1055-1062.